-
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Source: Buzz FX / 12 Jan 2025 02:45:17 America/New_York
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Shares of Allogene Therapeutics, Inc.
Read more...